Longevity biotech: a different strategy
The fastest way to bring longevity drugs to market may be extremely difficult but fundamentally simple: target aging
David Stanete
Longevity for dogs 101
For the past months I've been deep diving into the topic of longevity for dogs. This is the final result
The history of longevity biotech
What we've learned from more than 30 years of a story that has repeated itself time and again
Longevity for pets: from zero to one
Targeting deregulated nutrient-sensing and mitochondrial dysfunction to bring the first product to market that increases healthy lifespan in companion animals
Longevity for pets: why should we care
Systemic, physical and functional changes related to aging in dogs, cats and horses and how good of a model are each of them for aging in people
A mental model for aging drugs market readiness
Looking with a product mindset at the likelihood of aging interventions making their way from lab to real-world impact
Figuring out what to work on in the longevity field
Exploring the complexities of the longevity field to uncover opportunities for advancing healthy lifespan: a high level guide for newcomers
I left my CTO job to work on longevity
I know the chances of success are ridiculous. But hey, there is nothing else I'd rather do with my life right now
Lifestyle changes I made to decelerate aging
Both tiny and drastic lifestyle changes have a great impact on accelerating and decelerating the biology of aging
A coming of age for longevity
A change that brings many opportunities to improve our healthy lifespan, start new companies around longevity and accelerate research for life extension